Application of effective part of cockroach extract in preparing drug for inhibiting fungus growth
A technology of effective parts and extracts, which is applied in the field of preparation of antifungal infection drugs, can solve problems such as poor metabolic properties and physical and chemical properties, poor bioavailability, and inconvenient use for patients, and achieve potential social and economic benefits and increase income , Conducive to the effect of industrialization
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0023] Example 1 : Use D-101 macroporous adsorption resin to enrich the lyophilized powder raw material of effective parts of cockroaches
[0024] 1.1 Preparation of the alcoholic extract of Periplaneta americana: Add 3 kg of Periplaneta americana medicinal materials, add 10,000 ml of 55% ethanol, soak and extract at room temperature, extract 3 times, 24 hours each time. The extracts were combined, concentrated to dryness under reduced pressure, and dried in vacuum to obtain the alcoholic extract of Periplaneta americana.
[0025] 1.2 Preparation of different extracts from D-101 macroporous adsorption resin column chromatography: 20 grams of alcoholic extract of Periplaneta americana, mixed with 30 grams of D-101 macroporous adsorption resin, and 200 grams of D-101 macroporous Adsorption resin column, first eluted with water until colorless, then eluted with 30% ethanol-water solution until colorless, took 10 ml of the eluent and concentrated it to dryness under reduced press...
Embodiment 2
[0027] Example 2 : Detection of antifungal activity of effective parts of Periplaneta americana alcohol extract D-101 macroporous adsorption resin column chromatography 60% alcohol lotion
[0028] Referring to the standardized antifungal susceptibility test method proposed by the National Committee for Clinical Laboratory Standards (NCCLS), the in vitro antifungal activity of the effective fraction I-60 prepared in Example 1 was tested.
[0029] 2.1 Fungal standard strain:
[0030] Candida albicans ATCC10231: Provided by Chongqing Center for Disease Control;
[0031] Candida albicans ATCC90029 (5-FC drug-resistant strain): Provided by the Clinical Laboratory Center of the Ministry of Health of Beijing Hospital;
[0032] Candida albicans ATCC76615 (CS3): Provided by Changzheng Hospital Affiliated to Second Military Medical University.
[0033] Candida albicans 98001: provided by Wuhan Culture Collection Center;
[0034] Candida albicans ATCC76615:19 (Y0119): Provided by Na...
Embodiment 3
[0077] Example 3 : Acute toxicity (LD 50 )test
[0078] 3.1 Experimental materials:
[0079] Sample to be tested: the effective fraction I-60 prepared according to Example 1;
[0080] Solvent: 0.5%CMC-Na;
[0081] Animals: ICR mice, both male and female, weighing 19.0-20.9 g, were purchased from Shanghai Slack Experimental Animal Co., Ltd.
[0082] 3.2 Experimental method:
[0083] 3.2.1 Preparation of sample suspension: Weigh the effective fraction I-60 sample to prepare a suspension with a concentration of 50 mg / ml.
[0084] 3.2.2 Administration: 12 mice (half male and half female) were administered intragastrically with I-60 suspension of the effective part; the administration volume was 40 ml / kg, and the administration dose was 2000 mg / kg.
[0085] 3.2.3 Observation record: observe and record the reaction of the mice after administration.
[0086] 3.3 Experimental results: The feeding and activity of the animals were observed continuously for 10 days after administ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com